KALOWSKI LEE (CFO and President) sold 0.9% of their position (1.30K shares) of Q32 BIO INC. on the open market
Open‑market sale worth $10.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/14/2026ACC: 0001193125-26-421834
Officer· CFO and President
Since Feb 2026
-1.30K
Net shares
Net seller
$10.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.30K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.30K
Price / share
$8.32
Trade value
$10.82K
% of position
0.9%
10/6/2026
138.47K→137.17K
Total
Net shares
−1.30K
Net value
-$10.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/6/2026 | S · Sale | −1.30K | $8.32 | $10.82K | 0.9% | 138.47K | 137.17K |
| Total | −1.30K | -$10.82K | ||||||
Derivative Transactions0
No derivative transactions reported